Skip to main content
Vericel Corp logo

Vericel Corp — Investor Relations & Filings

Ticker · VCEL ISIN · US92346J1088 LEI · 54930076YM3PLTDR4B91 US Manufacturing
Open in API
Filings indexed 1,130 across all filing types
Latest filing 2012-06-27 Capital/Financing Update
Country US United States of America
Listing US VCEL

About Vericel Corp

https://vcel.com/

Vericel Corporation is a biopharmaceutical company that develops, manufactures, and commercializes advanced cell therapies for the sports medicine and severe burn care markets. The company's portfolio is centered on autologous (patient-specific) cell-based products. Key commercial products include MACI® (autologous cultured chondrocytes on porcine collagen membrane), a tissue-engineered product for the repair of symptomatic cartilage defects of the knee, and Epicel® (cultured epidermal autografts), a permanent skin replacement for patients with severe burns. Additionally, Vericel holds the exclusive North American commercial rights for NexoBrid®, a biological orphan product used for the removal of eschar in adults with deep partial-thickness or full-thickness thermal burns.

Recent filings

Filing Released Lang Actions
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 27, 2012, reporting a current event related to the company's intent to offer an exchange of outstanding warrants for common stock. It includes details about the offer, legal exemptions, and references a press release as an exhibit. The content focuses on a financing-related event (exchange offer of warrants for shares) and does not contain financial statements or earnings data. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. The document length is over 6000 characters, indicating it is a substantive filing rather than a brief announcement. Therefore, the appropriate classification is CAP with high confidence.
2012-06-27 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 27, 2012. It reports the entry into a material definitive agreement involving warrant exchange agreements and the issuance of common stock in exchange for warrants. The content focuses on a financing-related transaction involving equity securities, specifically the exchange of warrants for shares of common stock. There are no financial statements or comprehensive financial data presented, nor is this a full annual or quarterly report. The document is not a proxy, earnings release, or management discussion. The primary subject is a capital transaction updating shareholders and the market about changes in the company's capital structure. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length is over 5,000 characters and contains substantive information about the financing event, not just an announcement or certification, supporting a high confidence classification.
2012-06-27 English
SC TO-C Filing
Regulatory Filings
2012-06-27 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 14, 2012. The key content is under Item 5.02, which relates to the departure, election, or appointment of directors or certain officers, and compensatory arrangements of certain officers. Specifically, it discusses the approval of the 2011 bonus payment to the CEO by the Compensation Committee. There is no financial report or earnings data, nor is it an announcement of a report publication. The document focuses on management changes and compensation decisions. Therefore, it fits the category of Board/Management Information (MANG). The document length is 3267 characters, which is consistent with a typical 8-K filing for management changes rather than a full report or announcement.
2012-05-18 English
FORM 4/A -
Director's Dealing
2012-05-15 English
10-Q
Interim / Quarterly Report Q1 2012
2012-05-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.